Glucagonoma historical perspective: Difference between revisions
Jump to navigation
Jump to search
(Mahshid) |
|||
| (22 intermediate revisions by 3 users not shown) | |||
| Line 1: | Line 1: | ||
__NOTOC__ | __NOTOC__ | ||
{{Glucagonoma}} | {{Glucagonoma}} | ||
{{CMG}}{{AE}}{{PSD}} | {{CMG}}; {{AE}} {{PSD}}, {{MAD}} | ||
==Overview== | ==Overview== | ||
Glucagonoma was first | Glucagonoma was first described in 1942 by Becker. In 1966, McGavran was the first to report a case of [[hyperglucagonemia]] associated with cutaneous changes. In 1970, Wilkinson described the typical skin eruption in glucagonoma as [[necrolytic migratory erythema]]. | ||
==Historical Perspective== | ==Historical Perspective== | ||
* | *In 1942, glucagonoma was first described by Becker. | ||
*McGavran was first to | *Between 1942 and 1966, many authors tried to make associations between high level of [[glucagon]] and skin eruptions. | ||
*In 1966, The first well-documented case of glucagonoma was reported by McGavran in a female with [[skin lesions]] and [[glucose intolerance]]. The author was the first to describe a correlation between [[skin lesions]] and [[Islet cell tumor|islet-cell tumors]].<ref name="pmid22970401">{{cite journal| author=Afsharfard A, Atqiaee K, Lotfollahzadeh S, Alborzi M, Derakhshanfar A| title=Necrolytic migratory erythema as the first manifestation of glucagonoma. | journal=Case Rep Surg | year= 2012 | volume= 2012 | issue= | pages= 974210 | pmid=22970401 | doi=10.1155/2012/974210 | pmc=PMC3434377 | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=22970401 }} </ref> | |||
*In 1970, Wilkinson described the typical skin eruption in glucagonoma as [[necrolytic migratory erythema]].<ref name="pmid22970401" /> | |||
==References== | ==References== | ||
{{reflist|2}} | {{reflist|2}} | ||
{{WH}} | |||
[[Category: | {{WS}} | ||
[[Category:Medicine]] | |||
[[Category:Endocrinology]] | [[Category:Endocrinology]] | ||
[[Category:Up-To-Date]] | |||
[[Category:Oncology]] | |||
[[Category:Medicine]] | |||
[[Category:Gastroenterology]] | |||
[[Category:Surgery]] | |||
Latest revision as of 01:48, 27 November 2017
|
Glucagonoma Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Glucagonoma historical perspective On the Web |
|
American Roentgen Ray Society Images of Glucagonoma historical perspective |
|
Risk calculators and risk factors for Glucagonoma historical perspective |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Parminder Dhingra, M.D. [2], Mohammed Abdelwahed M.D[3]
Overview
Glucagonoma was first described in 1942 by Becker. In 1966, McGavran was the first to report a case of hyperglucagonemia associated with cutaneous changes. In 1970, Wilkinson described the typical skin eruption in glucagonoma as necrolytic migratory erythema.
Historical Perspective
- In 1942, glucagonoma was first described by Becker.
- Between 1942 and 1966, many authors tried to make associations between high level of glucagon and skin eruptions.
- In 1966, The first well-documented case of glucagonoma was reported by McGavran in a female with skin lesions and glucose intolerance. The author was the first to describe a correlation between skin lesions and islet-cell tumors.[1]
- In 1970, Wilkinson described the typical skin eruption in glucagonoma as necrolytic migratory erythema.[1]
References
- ↑ 1.0 1.1 Afsharfard A, Atqiaee K, Lotfollahzadeh S, Alborzi M, Derakhshanfar A (2012). "Necrolytic migratory erythema as the first manifestation of glucagonoma". Case Rep Surg. 2012: 974210. doi:10.1155/2012/974210. PMC 3434377. PMID 22970401.